Cycling#ECE2

Cycling is a low-impact aerobic exercise with exceptional longevity evidence. The Celis-Morales cohort study (BMJ, 2017; 263,450 UK participants) found that cycling commuters had 41% lower all-cause mortality (HR 0.59), 52% lower CVD incidence, and 45% lower cancer mortality compared to non-active commuters, independent of other leisure exercise. A 2021 systematic review and dose-response meta-analysis confirmed that any level of cycling reduces all-cause mortality risk, with the highest cycling levels associated with a 23% reduction (RR 0.77). The dose-response curve is non-linear: benefits are present even at very low cycling volumes, with diminishing but continuing returns at higher doses. For cardiovascular mortality specifically, an approximate optimum of ~130 minutes per week was identified.

Mechanistically, cycling provides a sustained, controllable cardiovascular stimulus. Moderate aerobic cycling raises VO2 max, reduces resting blood pressure, improves endothelial function, and lowers LDL cholesterol. Because cycling is non-weight-bearing, it is exceptionally joint-friendly, a practical advantage for people with knee, hip, or ankle pain who cannot tolerate running. It can be performed indoors on a stationary bike in any weather, supporting year-round adherence.

Unlike running, cycling allows sustained low-impact effort for extended durations, enabling even deconditioned individuals to accumulate significant weekly cardiovascular volume before overuse injury risk becomes relevant. As daily transport, cycling embeds aerobic conditioning into existing routines, the commute-cycling mortality data from the UK Biobank suggests this incidental exercise model is highly effective, removing the need for dedicated workout time. Cycling engages the quadriceps, glutes, calves, and hip flexors, and at higher intensities adds meaningful muscular conditioning alongside cardiovascular adaptation.

Mortality Reduction#

41% lower all-cause mortality; 23% reduction in dose-response meta-analysis. The evidence and practical framing for this claim are covered in the page narrative above.

Cardiovascular Fitness#

Improves VO2 max, lowers blood pressure and LDL cholesterol. The evidence and practical framing for this claim are covered in the page narrative above.

Cancer Risk Reduction#

45% lower cancer mortality in active commuter cohort. The evidence and practical framing for this claim are covered in the page narrative above.

Joint Friendly#

Non-weight-bearing; accessible to people with knee and hip pain. The evidence and practical framing for this claim are covered in the page narrative above.